Affecting all lots, serial numbers, and these models of the MiniMed 630G ... may result in the pump stopping insulin delivery significantly sooner than usually expected." Medtronic said this ...
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
GlobalData on MSN1mon
Medtronic shares dip after FDA tags insulin pump recall as Class IThe US Food and Drug Administration (FDA) has issued a Class I tag to Medtronic’s recall ... 600 series and 700 series pump ...
Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...
After an FDA warning, Medtronic has recalled two of its MiniMed insulin pump products that could be wirelessly interfered with by hackers. Medtronic thinks there’s no evidence that anyone using ...
That has left Medtronic and others in the insulin pump market scrambling to catch up, and the deal with EOFlow was the company’s solution to bridging the gap, with analysts suggesting that ...
notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe ...
Major medical device manufacturing company Medtronic has announced a US Food and Drugs Administration (FDA) class I recall of its MiniMed insulin pump system. This announcement comes during ...
This could result in the pump stopping insulin delivery sooner than expected and lead to issues that require medical intervention. Medtronic has received 170 reports of hyperglycemia and 11 ...
Insulin pump therapy, also known as continuous subcutaneous ... including Roche Diagnostics, Sanofi, Abbott, and Medtronic. G.A.F. is President and CEO of Kinexum, which advises multiple health ...
This could result in the pump stopping insulin delivery sooner than expected and lead to issues that require medical intervention. Medtronic has received 170 reports of hyperglycemia and 11 ...
GALWAY, Ireland, Oct. 4, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback